ACE-2/ANG1-7 ameliorates ER stress-induced apoptosis in seawater aspiration-induced acute lung injury

Abstract

Previous studies have shown that apoptosis of alveolar cells can be regulated by autocrine of angiotensin (ANG)II and its counter regulatory ACE-2/ANG1-7 axis. Our earlier study has shown that endoplasmic reticulum (ER) stress in response to seawater aspiration eventually led to apoptosis in lung tissue. In this study, we examined the hypothesis that ER stress-induced apoptosis in seawater aspiration-induced acute lung injury (ALI) might also be regulated by the ANGII/ANG1-7 system. ER stress was induced by seawater stimulation and proteasome inhibitor MG132 (an ER stress inductor). Moreover, ER stress in seawater-stimulated lung tissues and rat pulmonary microvascular endothelial cells (RPMVECs) promoted ANGII expression and decreased ACE-2/ANG1-7 expression. ER stress induced by seawater stimulation also led to apoptosis. Apoptosis induced by seawater stimulation and MG132 were inhibited by ANGII receptor blocker and abrogated by the addition of ANG1-7. These results suggest that apoptosis induced by ER stress in seawater aspiration-induced ALI is regulated by ANG II/ANG1-7 in lung tissues and RPMVECs. In addition, the active form of X-box binding protein 1 (XBP1), spliced XBP1 (XBP1s), a transcription factor that regulates ER-associated degradation genes during ER stress was significantly activated in seawater stimulated cells. Based on this phenomenon we designed a tandem gene, Wfs1 promoter (a target gene promoter of XBP1s)- ACE2 and ANG1-7 and transfected this tandem gene into seawater-stimulated cells. ACE-2/ANG1-7 expression were significantly promoted and apoptosis was inhibited in cells transfected with the tandem gene. These results suggest that stimulation of ACE-2/ANG1-7 may be a therapeutic target of ER stress-induced apoptosis in seawater aspiration-induced ALI.

COVID-19 infection, a potential threat to surgical patients and staff? A retrospective cohort study

“…Studies have indicated that COVID-19 acts on the ACE II receptor [ 2 ], which is mainly distributed on type II alveolar epithelial cells regulating lung compliance [ 23 ], but few are distributed on type I alveolar epithelial cells [ 24 ]. COVID-19 pneumonia can lead to dyspnea and chest tightness, even respiratory failure, so patients need high-flow oxygen support, even ventilator therapy.…”

Pathological Aspects of COVID-19 as a Conformational Disease and the Use of Pharmacological Chaperones as a Potential Therapeutic Strategy

“…Several studies suggest that ACE2-mediated signaling reduces the effects of ER stress (Zhang et al, 2018). Stimulation of ACE2 by the ligands angiotensin 1-7 suppresses apoptosis mediated by ER stress in alveolar epithelial cells with accumulation of mutant surfactant protein C (Uhal et al, 2013).…”

Renin-angiotensin-system, a potential pharmacological candidate, in acute respiratory distress syndrome during mechanical ventilation

“…The mechanisms of the beneficial effects on outcomes in these models include inhibition of apoptosis in AECs and pulmonary microvascular endothelial cells (PVMECs), as well as a reduction in the proliferation and migration of lung fibroblasts. For instance, studies by Ang-(1-7)/MasR enhances survival of AECs, which normally show excessive apoptosis in ARDS [63,64]. Gopallawa and colleagues found that Ang-(1-7)/MasR enhanced mitogen-activated protein kinase phosphatase-2 (MKP-2) which drives apoptosis of AECs [65].…”